Comparison of short-term efficacy of iron sucrose with those of ferric chloride in hemodialysis patients: An open-label study.

about

Comparison of short-term efficacy of iron sucrose with those of ferric chloride in hemodialysis patients: An open-label study.

Item

http://www.wikidata.org/entity/Q37593694

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Comparison of short-term effic ...... patients: An open-label study.

@en

Comparison of short-term effic ...... patients: An open-label study.

@nl

type

Item

label

Comparison of short-term effic ...... patients: An open-label study.

@en

Comparison of short-term effic ...... patients: An open-label study.

@nl

prefLabel

Comparison of short-term effic ...... patients: An open-label study.

@en

Comparison of short-term effic ...... patients: An open-label study.

@nl

P1476

Comparison of short-term effic ...... patients: An open-label study.

@en

P2093

Chia-Chao Wu

http://www.w3.org/2001/XMLSchema#string

Jenq-Shyong Chan

http://www.w3.org/2001/XMLSchema#string

Jin-Shuen Chen

http://www.w3.org/2001/XMLSchema#string

Jing-Shu Huang

http://www.w3.org/2001/XMLSchema#string

Kun-Lin Wu

http://www.w3.org/2001/XMLSchema#string

Pauling Chu

http://www.w3.org/2001/XMLSchema#string

Po-Jen Hsiao

http://www.w3.org/2001/XMLSchema#string

Wen-Fang Chiang

http://www.w3.org/2001/XMLSchema#string

P2860

Parenteral versus oral iron therapy for adults and children with chronic kidney disease

Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial.

Iron sucrose accelerates early atherogenesis by increasing superoxide production and upregulating adhesion molecules in CKD.

Intravenous ferric chloride hexahydrate supplementation induced endothelial dysfunction and increased cardiovascular risk among hemodialysis patients.

Maximal standard dose of parenteral iron for hemodialysis patients: an MRI-based decision tree learning analysis.

Safety in iron management.

Reassessment of Iron Biomarkers for Prediction of Dialysis Iron Overload: An MRI Study.

Poor response to treatment of renal anaemia with erythropoietin corrected by iron given intravenously.

A randomized, open-label trial of iron isomaltoside 1000 (Monofer®) compared with iron sucrose (Venofer®) as maintenance therapy in haemodialysis patients.

A randomized controlled trial of intensive periodontal therapy on metabolic and inflammatory markers in patients With ESRD: results of an exploratory study.

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4103/1735-1995.193171

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-11-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28163745

http://www.w3.org/2001/XMLSchema#string

P932

5244645

http://www.w3.org/2001/XMLSchema#string